aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence 1 year ago AnaIn Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast 1 year ago AnaIn Biopharma HighlightsClinical TrialsInnovationInvestments
Viking Therapeutics Launches Phase 3 VANQUISH Program for VK2735 in Obesity and Type 2 Diabetes 1 year ago AnaIn BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Metabolics Pharma Announces Positive Topline Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects 1 year ago AnaIn BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
MaaT Pharma Delivers Business Update Amid Positive Clinical and Commercial Milestones 1 year ago AnaIn Biopharma HighlightsClinical TrialsInnovationPartnershipsPharma Industry Updates
CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials, Offering New Hope for Obesity and Type 2 Diabetes Management 1 year ago AnaIn BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Ocular Therapeutix Advances OTX-TKI Axitinib Hydrogel with Positive Phase 1/2 and Registrational Trial Data 1 year ago AnaIn Biopharma ManufacturingClinical TrialsInnovationPharma Industry UpdatesTechnology
FDA Approves Dupilumab for Bullous Pemphigoid in Landmark Win for Sanofi and Regeneron 1 year ago AnaIn Biopharma HighlightsClinical TrialsFDA ApprovalsPeoplePharma Industry Updates
FDA Approves Nitisinone (HARLIKU) for Alkaptonuria: First Therapy for Rare Genetic Disorder Marks Milestone in Metabolic Disease 1 year ago AnaIn BreakthroughsFDA ApprovalsPeopleResearch Updates
Zealand Pharma Reports Positive Phase 1b Results for Dual GLP-1/GLP-2 Agonist Dapiglutide in Obesity and Metabolic Disease 1 year ago AnaIn Biopharma HighlightsBreakthroughsClinical TrialsInnovationResearch Updates
Clarity Pharmaceuticals and SpectronRx Announce Major U.S. Manufacturing Deal for 64Cu-SAR-bisPSMA Radiopharmaceutical 1 year ago AnaIn Biopharma ManufacturingClinical TrialsPartnershipsPharma Industry UpdatesTechnology
AbbVie Provides Update on VERONA Trial Evaluating Venetoclax in Newly Diagnosed Higher-Risk Myelodysplastic Syndromes 1 year ago AnaIn Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
CSL’s ANDEMBRY™ Gains FDA Approval as First Prophylactic Therapy Targeting Factor XIIa for Hereditary Angioedema 1 year ago AnaIn Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
Clarity Pharmaceuticals Reports Positive Topline Phase II SABRE Trial Data for SAR-Bombesin Diagnostic in Breast Cancer 1 year ago AnaIn Biopharma ManufacturingBreakthroughsClinical TrialsFDA ApprovalsIndustry ConferencesInnovationLeadersResearch UpdatesVenture Capital
ADC Therapeutics Shares Updated LOTIS-7 Clinical Trial Data Showing Strong Efficacy in Relapsed or Refractory Large B-Cell Lymphoma 1 year ago AnaIn Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
